← back to search

Evangelia K. Papachristou

Cancer Research UK ·
Area of research
Radiology, Nuclear Medicine and Imaging · Pathology and Forensic Medicine
Research interest
Research interests include Monoclonal and Polyclonal Antibodies Research, Lymphoma Diagnosis and Treatment, HER2/EGFR in Cancer Research, and Acute Myeloid Leukemia Research.
h-index
18
citations
2,050
works
126
NIH funding
primary concept
Medicine
email

Recent publications

KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in <i>NUP98</i> -Rearranged Acute Myeloid Leukemia
Cancer Discovery 2025cited by 10position: middledoi
Transcription factor switching drives subtype-specific pancreatic cancer
Nature Genetics 2025cited by 2position: middledoi
Posttranscriptional depletion of ribosome biogenesis factors engenders therapeutic vulnerabilities in <i>NPM1</i>-mutant AML
Blood 2025cited by 2position: middledoi
Tandem Duplications in <i>UBTF</i> Create XPO1-Dependent Nuclear Export Signals that Reveal a Leukemic Therapeutic Dependency
Blood Cancer Discovery 2025cited by 1position: middledoi
Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma
Cancer Discovery 2024cited by 27position: middledoi
Abstract C076: New insights into the role of FOXA1- HNF4 axis in pancreatic cancer
Cancer Research 2024cited by 0position: middledoi
Data from ZNF384 Fusion Oncoproteins Drive Lineage Aberrancy in Acute Leukemia
2023cited by 0position: middledoi
TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions
Cell Reports 2021cited by 59position: middledoi
Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia
Cell Reports 2021cited by 35position: middledoi
The distinct effects of MEK and GSK3 inhibition upon the methylome and transcriptome of mouse embryonic stem cells
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 3position: middledoi
IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis
Cancer Cell 2020cited by 254position: middledoi
Asparagine bioavailability governs metastasis in a model of breast cancer
Nature 2018cited by 551position: middledoi
Increased circulating resistin levels in early-onset breast cancer patients of normal body mass index correlate with lymph node negative involvement and longer disease free survival: a multi-center POSH cohort serum proteomics study
Breast Cancer Research 2018cited by 18position: middledoi
Abstract 1811: O-GlcNAc-dependent regulation of progesterone receptor function in breast cancer
Cancer Research 2018cited by 1position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Clive S. D’Santos · University of Cambridge5 papers (2018–2021)Kamal Kishore · Post Graduate Institute of Medical Education and Research4 papers (2020–2024)Jason S. Carroll · Brigham Young University4 papers (2020–2024)Igor Chernukhin · Bridge University3 papers (2020–2024)Rebecca Broome · The Francis Crick Institute2 papers (2020–2021)Rasmus Siersbæk · University of Southern Denmark2 papers (2020–2021)Clive S. D’Santos · Cancer Research UK Cambridge Center2 papers (2023–2024)Alasdair Russell · University of Cambridge2 papers (2020–2024)Danya Cheeseman · Cancer Research UK Cambridge Center2 papers (2020–2024)Jaewoo Choi · Center for Cancer Research1 papers (2024–2024)Kathryn G. Roberts · Dana-Farber Cancer Institute1 papers (2023–2023)Gregory J. Hannon · University of Cambridge1 papers (2018–2018)Spiros D. Garbis · Broadata Communications (United States)1 papers (2018–2018)Sanjeev Kumar · UNSW Sydney1 papers (2020–2020)Charles G. Mullighan · Dana-Farber Cancer Institute1 papers (2023–2023)Cory White · Merck (Japan)1 papers (2018–2018)Isabel Romero-Camarero · University of Manchester1 papers (2021–2021)Antigoni Manousopoulou · University of Southampton1 papers (2018–2018)Wolf Reik · Babraham Institute1 papers (2021–2021)Lisa A. Carey · University of North Carolina at Chapel Hill1 papers (2018–2018)